ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 38 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,000 | +27.3% | 3,413 | +85.5% | 0.00% | – |
| Q4 2019 | $11,000 | 0.0% | 1,840 | -14.8% | 0.00% | – |
| Q3 2019 | $11,000 | -26.7% | 2,160 | -10.7% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | -34.8% | 2,420 | -6.2% | 0.00% | 0.0% |
| Q1 2019 | $23,000 | +9.5% | 2,580 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $21,000 | -62.5% | 2,572 | -36.8% | 0.00% | -66.7% |
| Q3 2018 | $56,000 | -67.1% | 4,072 | -81.0% | 0.00% | -72.7% |
| Q2 2018 | $170,000 | +750.0% | 21,415 | +684.1% | 0.01% | +1000.0% |
| Q1 2018 | $20,000 | +122.2% | 2,731 | +101.8% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -10.0% | 1,353 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | -9.1% | 1,364 | -44.3% | 0.00% | 0.0% |
| Q2 2017 | $11,000 | – | 2,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |